<p>Montecito Bank  Trust 在第三季度收购了 Thermo Fisher Scientific Inc.（纽约证券交易所代码：TMO - 免费报告）的一项新股份，根据其最近向证券交易委员会提交的 13F 表格。该基金收购了 2,959 股这家医疗研究公司的股票，价值约为 1,435,000 美元。</p>
<ul>
<li>机构热爱这三家公司，你也应该吗？</li>
</ul>
<p>其他一些机构投资者也调整了他们对 TMO 的持股。新约定信托公司 N.A. 在第三季度购买了价值约 228,000 美元的 Thermo Fisher Scientific 股票的新股份。McLean Asset Management Corp 在第三季度将其在 Thermo Fisher Scientific 的持股增加了 4.7%。McLean Asset Management Corp 目前拥有 627 股这家医疗研究公司的股票，价值 304,000 美元，此前在此期间又购买了 28 股。Channel Wealth LLC 在第三季度购买了价值 210,000 美元的 Thermo Fisher Scientific 股票的新头寸。ST Germain D J Co. Inc. 在第三季度将其在 Thermo Fisher Scientific 的持股增加了 7.7%。ST Germain D J Co. Inc. 目前拥有 3,947 股这家医疗研究公司的股票，价值 1,914,000 美元，此前在上个季度又收购了 281 股。最后，Grant Private Wealth Management Inc 在第三季度购买了价值约 457,000 美元的 Thermo Fisher Scientific 新股份。89.23% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>Thermo Fisher Scientific 股票表现</h2>
<p>TMO 的股票在周四开盘价为 562.58 美元。Thermo Fisher Scientific Inc. 的 12 个月低点为 385.46 美元，12 个月高点为 610.97 美元。该股票的 50 天移动平均价格为 567.63 美元，200 天移动平均价格为 495.07 美元。该公司的流动比率为 1.50，速动比率为 1.11，债务与股本比率为 0.62。该公司的市值为 2,113.7 亿美元，市盈率为 32.50，市盈增长比率为 4.22，贝塔值为 0.90。</p>
<ul>
<li>这三只股票通过回购来传递市场信心</li>
</ul>
<p>Thermo Fisher Scientific（纽约证券交易所代码：TMO - 获取免费报告）最近在 10 月 22 日（星期三）公布了其财报。这家医疗研究公司报告的每股收益（EPS）为 5.79 美元，超出市场共识预期的 5.50 美元，超出幅度为 0.29 美元。该公司在本季度的收入为 111.2 亿美元，而分析师预期为 109 亿美元。Thermo Fisher Scientific 的股本回报率为 16.97%，净利润率为 15.02%。该公司的季度收入较去年同期增长了 4.9%。在去年同期，该公司发布的每股收益为 5.28 美元。Thermo Fisher Scientific 将其 2025 财年的指导目标设定为 22.600-22.860 每股收益。股票研究分析师预测，Thermo Fisher Scientific Inc. 本财年的每股收益将达到 23.28 美元。</p>
<p>Thermo Fisher Scientific 宣布其董事会已于 11 月 6 日（星期四）启动了一项股票回购计划，允许公司回购价值 50 亿美元的股票。该回购授权允许这家医疗研究公司通过公开市场购买回购最多 2.4% 的股票。股票回购计划通常表明公司的领导层认为其股票被低估。</p>
<h2>Thermo Fisher Scientific 股息公告</h2>
<ul>
<li>现金流关注：Thermo Fisher、能源转移和网易</li>
</ul>
<p>该公司还最近宣布了一项季度股息，将于 1 月 15 日（星期四）支付。12 月 15 日（星期一）的登记投资者将获得 0.43 美元的股息。除息日期为 12 月 15 日（星期一）。这代表着年化股息为 1.72 美元，收益率为 0.3%。Thermo Fisher Scientific 的股息支付比率（DPR）为 9.94%。</p>
<h2>Thermo Fisher Scientific 内部活动</h2>
<p>在相关消息中，首席运营官 Michel Lagarde 于 12 月 4 日（星期四）出售了 22,046 股公司的股票。该股票以平均价格 563.56 美元出售，总价值为 12,424,243.76 美元。交易后，首席运营官直接持有 84,117 股公司的股票，价值 47,404,976.52 美元。这代表着其持股减少了 20.77%。该交易已在证券交易委员会的法律文件中披露，相关信息可在此链接查看。此外，副总裁 Lisa P. Britt 于 11 月 12 日（星期三）出售了 1,058 股 Thermo Fisher Scientific 股票。该股票以平均价格 588.26 美元出售，总价值为 622,379.08 美元。出售后，副总裁直接持有 13,087 股公司的股票，价值约 7,698,558.62 美元。这代表着其持股减少了 7.48%。该销售的 SEC 文件提供了更多信息。过去 90 天内，内部人士已出售价值 86,507,282 美元的 149,271 股公司股票。0.33% 的股票由内部人士持有。</p>
<h2>华尔街分析师观点</h2>
<p>TMO 最近成为几份研究报告的主题。Weiss Ratings 在 10 月 14 日的报告中重申了对赛默飞世尔股票的 &#34;持有 (c)&#34; 评级。摩根士丹利在 12 月 2 日的研究报告中将赛默飞世尔的目标价格从 656.00 美元上调至 670.00 美元，并给予该股票 &#34;超配&#34; 评级。花旗集团在 12 月 11 日的研究报告中将赛默飞世尔的评级从 &#34;中性&#34; 上调至 &#34;买入&#34;，并将其目标价格从 580.00 美元提高至 660.00 美元。Evercore ISI 在 10 月 7 日的研究报告中将赛默飞世尔的目标价格从 525.00 美元上调至 590.00 美元，并给予该股票 &#34;跑赢大盘&#34; 评级。最后，汇丰全球研究在 12 月 1 日的研究报告中将赛默飞世尔的评级从 &#34;持有&#34; 上调至 &#34;强烈买入&#34;。一位研究分析师给予该股票 &#34;强烈买入&#34; 评级，二十位分析师给予 &#34;买入&#34; 评级，三位分析师给予 &#34;持有&#34; 评级。根据 MarketBeat.com 的数据，赛默飞世尔的平均评级为 &#34;适度买入&#34;，平均目标价格为 616.60 美元。</p>
<p><strong>阅读我们关于 TMO 的最新研究报告</strong></p>
<h2>赛默飞世尔公司简介</h2>
<p>(免费报告)</p>
<p>赛默飞世尔科技公司在北美、欧洲、亚太及国际市场提供生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务。公司的生命科学解决方案部门为生物和医学研究、药物和疫苗的发现与生产以及感染和疾病的诊断提供试剂、仪器和耗材；解决方案包括生物科学、遗传科学和生物生产，服务于制药、生物技术、农业、临床、医疗保健、学术和政府市场。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们认为比赛默飞世尔更好的股票</li>
<li>现在买入宝洁公司，趁其创下新高之前</li>
<li>在上涨 35% 后，分析师关注铜业巨头自由港的更多上涨空间</li>
<li>零售投资者如何交易多伦多证券交易所 (TSX)？</li>
<li>为什么 SpaceX 的 IPO 可能成为 GOOGL 股票的重大催化剂</li>
<li>万亿美元市值的意义超越了一个数字</li>
<li>Upwork 能否维持其复苏？看涨和看跌的理由</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在赛默飞世尔吗？</h2>
<p>在你考虑赛默飞世尔之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而赛默飞世尔并不在名单上。</p>
<p>虽然赛默飞世尔目前在分析师中获得 &#34;适度买入&#34; 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

赛默飞世尔

<p>Montecito Bank & Trust 在第三季度收购了 2,959 股赛默飞世尔，价值 1,435,000 美元。其他机构投资者也调整了他们的持股。赛默飞世尔的股票开盘价为 562.58 美元，市值为 2,113.7 亿美元。该公司报告了本季度每股收益为 5.79 美元，超出预期。公司启动了一项 50 亿美元的股票回购计划，并宣布了每季度 0.43 美元的股息。内部人士销售包括首席运营官 Michel Lagarde 出售了 22,046 股</p>

<p>Montecito Bank &amp; Trust acquired a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,959 shares of the medical research company's stock, valued at approximately $1,435,000.</p>
<div class="lb-trans"><p>Montecito Bank  Trust 在第三季度收购了 Thermo Fisher Scientific Inc.（纽约证券交易所代码：TMO - 免费报告）的一项新股份，根据其最近向证券交易委员会提交的 13F 表格。该基金收购了 2,959 股这家医疗研究公司的股票，价值约为 1,435,000 美元。</p>
</div><ul>
<li>Institutions Love These 3 Companies, Should You As Well?</li>
</ul>
<div class="lb-trans"><ul>
<li>机构热爱这三家公司，你也应该吗？</li>
</ul>
</div><p>A number of other institutional investors have also modified their holdings of TMO. New Covenant Trust Company N.A. purchased a new stake in shares of Thermo Fisher Scientific in the third quarter valued at approximately $228,000. McLean Asset Management Corp lifted its holdings in shares of Thermo Fisher Scientific by 4.7% in the 3rd quarter. McLean Asset Management Corp now owns 627 shares of the medical research company's stock worth $304,000 after buying an additional 28 shares during the period. Channel Wealth LLC bought a new position in shares of Thermo Fisher Scientific during the 3rd quarter worth $210,000. ST Germain D J Co. Inc. raised its holdings in shares of Thermo Fisher Scientific by 7.7% in the third quarter. ST Germain D J Co. Inc. now owns 3,947 shares of the medical research company's stock valued at $1,914,000 after acquiring an additional 281 shares in the last quarter. Finally, Grant Private Wealth Management Inc purchased a new stake in Thermo Fisher Scientific in the third quarter worth about $457,000. 89.23% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他一些机构投资者也调整了他们对 TMO 的持股。新约定信托公司 N.A. 在第三季度购买了价值约 228,000 美元的 Thermo Fisher Scientific 股票的新股份。McLean Asset Management Corp 在第三季度将其在 Thermo Fisher Scientific 的持股增加了 4.7%。McLean Asset Management Corp 目前拥有 627 股这家医疗研究公司的股票，价值 304,000 美元，此前在此期间又购买了 28 股。Channel Wealth LLC 在第三季度购买了价值 210,000 美元的 Thermo Fisher Scientific 股票的新头寸。ST Germain D J Co. Inc. 在第三季度将其在 Thermo Fisher Scientific 的持股增加了 7.7%。ST Germain D J Co. Inc. 目前拥有 3,947 股这家医疗研究公司的股票，价值 1,914,000 美元，此前在上个季度又收购了 281 股。最后，Grant Private Wealth Management Inc 在第三季度购买了价值约 457,000 美元的 Thermo Fisher Scientific 新股份。89.23% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Thermo Fisher Scientific Stock Performance</h2>
<div class="lb-trans"><h2>Thermo Fisher Scientific 股票表现</h2>
</div><p>Shares of TMO opened at $562.58 on Thursday. Thermo Fisher Scientific Inc. has a 12 month low of $385.46 and a 12 month high of $610.97. The stock has a fifty day moving average price of $567.63 and a 200-day moving average price of $495.07. The company has a current ratio of 1.50, a quick ratio of 1.11 and a debt-to-equity ratio of 0.62. The firm has a market cap of $211.37 billion, a PE ratio of 32.50, a P/E/G ratio of 4.22 and a beta of 0.90.</p>
<div class="lb-trans"><p>TMO 的股票在周四开盘价为 562.58 美元。Thermo Fisher Scientific Inc. 的 12 个月低点为 385.46 美元，12 个月高点为 610.97 美元。该股票的 50 天移动平均价格为 567.63 美元，200 天移动平均价格为 495.07 美元。该公司的流动比率为 1.50，速动比率为 1.11，债务与股本比率为 0.62。该公司的市值为 2,113.7 亿美元，市盈率为 32.50，市盈增长比率为 4.22，贝塔值为 0.90。</p>
</div><ul>
<li>These 3 Stocks Are Using Buybacks to Signal Market Confidence</li>
</ul>
<div class="lb-trans"><ul>
<li>这三只股票通过回购来传递市场信心</li>
</ul>
</div><p>Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its earnings results on Wednesday, October 22nd. The medical research company reported $5.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.50 by $0.29. The company had revenue of $11.12 billion for the quarter, compared to analyst estimates of $10.90 billion. Thermo Fisher Scientific had a return on equity of 16.97% and a net margin of 15.02%.The firm's quarterly revenue was up 4.9% compared to the same quarter last year. During the same period in the prior year, the company posted $5.28 EPS. Thermo Fisher Scientific has set its FY 2025 guidance at 22.600-22.860 EPS. Equities research analysts predict that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Thermo Fisher Scientific（纽约证券交易所代码：TMO - 获取免费报告）最近在 10 月 22 日（星期三）公布了其财报。这家医疗研究公司报告的每股收益（EPS）为 5.79 美元，超出市场共识预期的 5.50 美元，超出幅度为 0.29 美元。该公司在本季度的收入为 111.2 亿美元，而分析师预期为 109 亿美元。Thermo Fisher Scientific 的股本回报率为 16.97%，净利润率为 15.02%。该公司的季度收入较去年同期增长了 4.9%。在去年同期，该公司发布的每股收益为 5.28 美元。Thermo Fisher Scientific 将其 2025 财年的指导目标设定为 22.600-22.860 每股收益。股票研究分析师预测，Thermo Fisher Scientific Inc. 本财年的每股收益将达到 23.28 美元。</p>
</div><p>Thermo Fisher Scientific declared that its Board of Directors has initiated a stock repurchase program on Thursday, November 6th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the medical research company to repurchase up to 2.4% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's leadership believes its stock is undervalued.</p>
<div class="lb-trans"><p>Thermo Fisher Scientific 宣布其董事会已于 11 月 6 日（星期四）启动了一项股票回购计划，允许公司回购价值 50 亿美元的股票。该回购授权允许这家医疗研究公司通过公开市场购买回购最多 2.4% 的股票。股票回购计划通常表明公司的领导层认为其股票被低估。</p>
</div><h2>Thermo Fisher Scientific Dividend Announcement</h2>
<div class="lb-trans"><h2>Thermo Fisher Scientific 股息公告</h2>
</div><ul>
<li>Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase</li>
</ul>
<div class="lb-trans"><ul>
<li>现金流关注：Thermo Fisher、能源转移和网易</li>
</ul>
</div><p>The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Monday, December 15th will be paid a $0.43 dividend. The ex-dividend date is Monday, December 15th. This represents a $1.72 dividend on an annualized basis and a yield of 0.3%. Thermo Fisher Scientific's dividend payout ratio (DPR) is 9.94%.</p>
<div class="lb-trans"><p>该公司还最近宣布了一项季度股息，将于 1 月 15 日（星期四）支付。12 月 15 日（星期一）的登记投资者将获得 0.43 美元的股息。除息日期为 12 月 15 日（星期一）。这代表着年化股息为 1.72 美元，收益率为 0.3%。Thermo Fisher Scientific 的股息支付比率（DPR）为 9.94%。</p>
</div><h2>Insider Activity at Thermo Fisher Scientific</h2>
<div class="lb-trans"><h2>Thermo Fisher Scientific 内部活动</h2>
</div><p>In related news, COO Michel Lagarde sold 22,046 shares of the company's stock in a transaction on Thursday, December 4th. The stock was sold at an average price of $563.56, for a total value of $12,424,243.76. Following the transaction, the chief operating officer directly owned 84,117 shares of the company's stock, valued at $47,404,976.52. This represents a 20.77% decrease in their position. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available at this hyperlink. Also, VP Lisa P. Britt sold 1,058 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $588.26, for a total value of $622,379.08. Following the sale, the vice president directly owned 13,087 shares of the company's stock, valued at approximately $7,698,558.62. This represents a 7.48% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 149,271 shares of company stock worth $86,507,282 in the last 90 days. 0.33% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在相关消息中，首席运营官 Michel Lagarde 于 12 月 4 日（星期四）出售了 22,046 股公司的股票。该股票以平均价格 563.56 美元出售，总价值为 12,424,243.76 美元。交易后，首席运营官直接持有 84,117 股公司的股票，价值 47,404,976.52 美元。这代表着其持股减少了 20.77%。该交易已在证券交易委员会的法律文件中披露，相关信息可在此链接查看。此外，副总裁 Lisa P. Britt 于 11 月 12 日（星期三）出售了 1,058 股 Thermo Fisher Scientific 股票。该股票以平均价格 588.26 美元出售，总价值为 622,379.08 美元。出售后，副总裁直接持有 13,087 股公司的股票，价值约 7,698,558.62 美元。这代表着其持股减少了 7.48%。该销售的 SEC 文件提供了更多信息。过去 90 天内，内部人士已出售价值 86,507,282 美元的 149,271 股公司股票。0.33% 的股票由内部人士持有。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>TMO has been the subject of several recent research reports. Weiss Ratings restated a &#34;hold (c)&#34; rating on shares of Thermo Fisher Scientific in a report on Tuesday, October 14th. Morgan Stanley boosted their price objective on shares of Thermo Fisher Scientific from $656.00 to $670.00 and gave the stock an &#34;overweight&#34; rating in a research note on Tuesday, December 2nd. Citigroup raised Thermo Fisher Scientific from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and increased their target price for the company from $580.00 to $660.00 in a research report on Thursday, December 11th. Evercore ISI boosted their price target on Thermo Fisher Scientific from $525.00 to $590.00 and gave the stock an &#34;outperform&#34; rating in a research report on Tuesday, October 7th. Finally, Hsbc Global Res upgraded Thermo Fisher Scientific from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Monday, December 1st. One research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Thermo Fisher Scientific has an average rating of &#34;Moderate Buy&#34; and an average target price of $616.60.</p>
<div class="lb-trans"><p>TMO 最近成为几份研究报告的主题。Weiss Ratings 在 10 月 14 日的报告中重申了对赛默飞世尔股票的 &#34;持有 (c)&#34; 评级。摩根士丹利在 12 月 2 日的研究报告中将赛默飞世尔的目标价格从 656.00 美元上调至 670.00 美元，并给予该股票 &#34;超配&#34; 评级。花旗集团在 12 月 11 日的研究报告中将赛默飞世尔的评级从 &#34;中性&#34; 上调至 &#34;买入&#34;，并将其目标价格从 580.00 美元提高至 660.00 美元。Evercore ISI 在 10 月 7 日的研究报告中将赛默飞世尔的目标价格从 525.00 美元上调至 590.00 美元，并给予该股票 &#34;跑赢大盘&#34; 评级。最后，汇丰全球研究在 12 月 1 日的研究报告中将赛默飞世尔的评级从 &#34;持有&#34; 上调至 &#34;强烈买入&#34;。一位研究分析师给予该股票 &#34;强烈买入&#34; 评级，二十位分析师给予 &#34;买入&#34; 评级，三位分析师给予 &#34;持有&#34; 评级。根据 MarketBeat.com 的数据，赛默飞世尔的平均评级为 &#34;适度买入&#34;，平均目标价格为 616.60 美元。</p>
</div><p><strong>Read Our Latest Research Report on TMO</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 TMO 的最新研究报告</strong></p>
</div><h2>Thermo Fisher Scientific Profile</h2>
<div class="lb-trans"><h2>赛默飞世尔公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.</p>
<div class="lb-trans"><p>赛默飞世尔科技公司在北美、欧洲、亚太及国际市场提供生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务。公司的生命科学解决方案部门为生物和医学研究、药物和疫苗的发现与生产以及感染和疾病的诊断提供试剂、仪器和耗材；解决方案包括生物科学、遗传科学和生物生产，服务于制药、生物技术、农业、临床、医疗保健、学术和政府市场。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Thermo Fisher Scientific</li>
<li>Buy P&amp;G Now, Before It Sets A New All-Time High</li>
<li>Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport</li>
<li>How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?</li>
<li>Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock</li>
<li>The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number</li>
<li>Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比赛默飞世尔更好的股票</li>
<li>现在买入宝洁公司，趁其创下新高之前</li>
<li>在上涨 35% 后，分析师关注铜业巨头自由港的更多上涨空间</li>
<li>零售投资者如何交易多伦多证券交易所 (TSX)？</li>
<li>为什么 SpaceX 的 IPO 可能成为 GOOGL 股票的重大催化剂</li>
<li>万亿美元市值的意义超越了一个数字</li>
<li>Upwork 能否维持其复苏？看涨和看跌的理由</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=TMO"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Thermo Fisher Scientific Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在赛默飞世尔吗？</h2>
</div><p>Before you consider Thermo Fisher Scientific, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑赛默飞世尔之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而赛默飞世尔并不在名单上。</p>
</div><p>While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然赛默飞世尔目前在分析师中获得 &#34;适度买入&#34; 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Montecito Bank & Trust 购入了 2,959 股赛默飞世尔科技公司股票 $TMO